Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aliza Paudyal"'
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: About 90% of liver cancer-related deaths are caused by hepatocellular carcinoma (HCC). N7-methylguanosine (m7G) modification is associated with the biological process and regulation of various diseases. To the best of our knowledge, its r
Externí odkaz:
https://doaj.org/article/d7c262b33e574c80a9014c7ef0abb01b
Autor:
Wen-Jie Ma, Yan-Wen Jin, Aliza Paudyal, Pranita Paudyal, Fu-Yu Li, Parbatraj Regmi, Hai-Jie Hu, Fei Liu
Publikováno v:
European Journal of Surgical Oncology. 48:160-168
Tumor budding is a significant prognostic indicator for poor survival of several solid tumors. However, due to the lack of a standard scoring system, its clinical application for biliary tract cancer (BTC) is limited.To identify the prognostic signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d375b0bc86d03d2e1cbd1fcb254548
https://doi.org/10.1016/j.ejso.2021.08.008
https://doi.org/10.1016/j.ejso.2021.08.008
Publikováno v:
Dermatologic Therapy. 34
Refractory dermatomyositis (DM) is defined as cases that do not show improvement after initial treatment with two different immunosuppressives combined with corticosteroids with or without intravenous immunoglobulins. In recent years, few studies hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606888e2e6584a5c4b240ac95dbe5da7
https://doi.org/10.1111/dth.14939
https://doi.org/10.1111/dth.14939
Autor:
Fu-Yu Li, Hai-Jie Hu, Ram Babu Sah, Aliza Paudyal, Wen-Jie Ma, Tian-Run Lv, Parbatraj Regmi, Yan-Wen Jin
Publikováno v:
Surgical oncology. 39
Sorafenib is the standard treatment for patients with advanced HCC with improvement in survival and radiologic progression of the disease. Recently, few studies have advocated the Sorafenib + HAIC combination therapy results in better overall surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbefbb4a3070f64a0a64cb077e071851
https://pubmed.ncbi.nlm.nih.gov/34583091
https://pubmed.ncbi.nlm.nih.gov/34583091
Publikováno v:
Rheumatology. 61:e62-e63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf75dee935f342fd5dbf953e74ff8718
https://doi.org/10.1093/rheumatology/keab759
https://doi.org/10.1093/rheumatology/keab759
Autor:
Aliza Paudyal, Cong-Dun Ran, Wen-Jie Ma, Nan-Sheng Cheng, Fu-Yu Li, Yin Chang-Hao, Hai-Jie Hu, Jun-Ke Wang, Parbatraj Regmi, Fei Liu
Publikováno v:
Surgical endoscopy. 35(12)
Surgical treatment is still the most effective treatment for gallbladder cancer. For the patients with stage T1b and above, the current guidelines recommend the extended radical operation, and oncologic extended resection can benefit the survival of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abe998a2f020c30f21bccb266c02c1f
https://pubmed.ncbi.nlm.nih.gov/33174099
https://pubmed.ncbi.nlm.nih.gov/33174099